title: Drug immunotargeting for carcinomas: a reality at last?
authors: Bristol Myers Squibb Pharmaceutical Research Institute, Princeton, NJ.
authors: A M
authors: AM
authors: Casazza
authors: P A
authors: PA
authors: Trail
authors: K E
authors: KE
authors: Hellström
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002277:Carcinoma / Q000473:pathology / Q000628:therapy*; D003110:Colonic Neoplasms / Q000628:therapy; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000628:therapy; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation
chemical_list: D000911:Antibodies, Monoclonal; D018796:Immunoconjugates; D004317:Doxorubicin